IL37 and enthesitis: The pathophysiology of enthesitis can be acknowledged by explaining the role of biomechanics, prostaglandin E2-mediated vasodilation, the activation of innate immune cells in the initiation phase of enthesitis, and the role of entheseal interleukine-23 (IL-23) responsive cells that augment inflammation [32].